Matsumoto T, Aizawa O, Nozaki T, Sato T
Atomic Energy Research Laboratory, Musashi Institute of Technology, Kawasaki-shi, Japan.
Pigment Cell Res. 1989 Jul-Aug;2(4):240-5. doi: 10.1111/j.1600-0749.1989.tb00198.x.
Boron neutron capture therapy (BNCT) of malignant brain tumors has been efficiently performed since March 1977, and the first human case of malignant melanoma was also successfully treated on July 1987 in our reactor (Musashi reactor, TRIGA-II, 100 kW). To obtain both good irradiation field characteristics and a better irradiation facility, some tests and developments have been continued in accordance with the study of medical and biological irradiations. The results of these evaluations and a new approach are presented.
自1977年3月以来，恶性脑肿瘤的硼中子俘获疗法（BNCT）已得到有效开展，1987年7月，首例恶性黑色素瘤患者在我们的反应堆（武藏反应堆，TRIGA-II，100千瓦）中也成功接受了治疗。为了获得良好的照射野特性和更好的照射设备，根据医学和生物照射研究持续进行了一些测试和研发工作。本文介绍了这些评估结果和一种新方法。
